Wealth Enhancement Advisory Services LLC Acquires 1,337 Shares of Teleflex Incorporated (NYSE:TFX)

Wealth Enhancement Advisory Services LLC raised its stake in shares of Teleflex Incorporated (NYSE:TFX) by 72.7% during the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 3,177 shares of the medical technology company’s stock after purchasing an additional 1,337 shares during the period. Wealth Enhancement Advisory Services LLC’s holdings in Teleflex were worth $786,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other institutional investors and hedge funds have also recently modified their holdings of TFX. Janus Henderson Group PLC boosted its stake in shares of Teleflex by 12.0% during the 1st quarter. Janus Henderson Group PLC now owns 5,409,317 shares of the medical technology company’s stock worth $1,223,424,000 after purchasing an additional 581,312 shares during the period. Point72 Asset Management L.P. boosted its holdings in Teleflex by 564.3% during the 2nd quarter. Point72 Asset Management L.P. now owns 310,484 shares of the medical technology company’s stock valued at $65,304,000 after acquiring an additional 263,743 shares during the period. Cooke & Bieler LP grew its position in Teleflex by 23.3% in the 2nd quarter. Cooke & Bieler LP now owns 912,797 shares of the medical technology company’s stock valued at $191,989,000 after acquiring an additional 172,335 shares during the last quarter. Ceredex Value Advisors LLC purchased a new stake in Teleflex in the second quarter worth $25,550,000. Finally, National Bank of Canada FI lifted its position in shares of Teleflex by 1,008.2% during the second quarter. National Bank of Canada FI now owns 115,343 shares of the medical technology company’s stock worth $24,388,000 after purchasing an additional 104,935 shares during the last quarter. Hedge funds and other institutional investors own 95.62% of the company’s stock.

Analyst Upgrades and Downgrades

Several research firms recently commented on TFX. Royal Bank of Canada reduced their price target on shares of Teleflex from $275.00 to $245.00 and set an “outperform” rating on the stock in a research note on Friday, November 1st. Stephens boosted their price target on Teleflex from $275.00 to $290.00 and gave the company an “overweight” rating in a report on Friday, August 2nd. Mizuho reduced their price objective on Teleflex from $275.00 to $250.00 and set a “neutral” rating on the stock in a report on Friday, November 1st. Truist Financial reaffirmed a “hold” rating and set a $227.00 target price (down from $255.00) on shares of Teleflex in a research report on Monday. Finally, Needham & Company LLC reissued a “hold” rating on shares of Teleflex in a research report on Friday, November 1st. Four equities research analysts have rated the stock with a hold rating and six have given a buy rating to the company’s stock. According to MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and a consensus target price of $259.25.

Insiders Place Their Bets

In other Teleflex news, Director Stuart A. Randle sold 2,674 shares of the business’s stock in a transaction that occurred on Friday, August 16th. The shares were sold at an average price of $238.93, for a total transaction of $638,898.82. Following the sale, the director now owns 5,496 shares of the company’s stock, valued at approximately $1,313,159.28. The trade was a 0.00 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Corporate insiders own 1.43% of the company’s stock.

Teleflex Trading Down 0.8 %

TFX opened at $201.92 on Thursday. Teleflex Incorporated has a 12 month low of $195.51 and a 12 month high of $257.85. The stock has a fifty day moving average price of $237.29 and a 200-day moving average price of $223.96. The firm has a market cap of $9.38 billion, a price-to-earnings ratio of 40.14, a PEG ratio of 2.12 and a beta of 1.18. The company has a current ratio of 2.42, a quick ratio of 1.39 and a debt-to-equity ratio of 0.37.

Teleflex (NYSE:TFX) last released its quarterly earnings results on Thursday, October 31st. The medical technology company reported $3.49 EPS for the quarter, beating the consensus estimate of $3.38 by $0.11. The business had revenue of $764.40 million during the quarter, compared to analyst estimates of $768.68 million. Teleflex had a net margin of 7.85% and a return on equity of 14.19%. The company’s quarterly revenue was up 2.4% on a year-over-year basis. During the same period in the prior year, the firm posted $3.64 earnings per share. As a group, equities research analysts anticipate that Teleflex Incorporated will post 13.98 earnings per share for the current fiscal year.

Teleflex Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Monday, December 16th. Shareholders of record on Friday, November 15th will be paid a $0.34 dividend. This represents a $1.36 dividend on an annualized basis and a yield of 0.67%. The ex-dividend date is Friday, November 15th. Teleflex’s dividend payout ratio (DPR) is presently 27.04%.

Teleflex Company Profile

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.